Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
27.11
+1.23 (4.75%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.51 billion as of October 9, 2026. It is the 8,110th most valuable company in the world and the 1,981st biggest in the United States. Its market cap has increased by 20.10% in one year.
Market Cap
1.51B
Enterprise Value
1.07B
1-Year Change
20.10%
Global Rank
Country Rank
#1,981 United States
Category
ChartMarket Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.51B, an increase of 119.77%. That is a compound annual growth rate of 59.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 1.51B | -24.46% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 1.53B |
| Ultragenyx Pharmaceutical | 1.53B |
| Immunocore Holdings | 1.52B |
| Innoviva | 1.52B |
| Taysha Gene Therapies | 1.46B |
| Rapport Therapeutics | 1.45B |
| Nektar Therapeutics | 1.44B |
| Hemab Therapeutics Holdings | 1.44B |